The Evaluation of Cardiovascular Risk in Diabetic Patients Cover

.blurhash-client-img { display: none !important; }

The Evaluation of Cardiovascular Risk in Diabetic Patients

European Pharmaceutical Journal

Volume 69 (2022): Issue 1 (January 2022)

By: S. Kosirova, D. Rubintova, J. Lacka, J. Klimas, T. Foltanova and I. Tumova

Open Access

|Apr 2022

Authors

S. Kosirova

stanislava.kosirova@uniba.sk

Comenius University Bratislava, Faculty of Pharmacy, Bratislava, SLOVAKIA

D. Rubintova

Trnava, Slovakia

J. Lacka

Trnava, Slovakia

J. Klimas

Comenius University Bratislava, Faculty of Pharmacy, Bratislava, SLOVAKIA

T. Foltanova

Comenius University Bratislava, Faculty of Pharmacy, Bratislava, SLOVAKIA

I. Tumova

Comenius University Bratislava, Faculty of Pharmacy, Bratislava, SLOVAKIA

DOI: https://doi.org/10.2478/afpuc-2022-0001 | Journal eISSN: 2453-6725

Journal RSS Feed

Language: English

Page range: 1 - 8

Submitted on: Aug 6, 2021

|

Accepted on: Nov 5, 2021

|

Published on: Apr 4, 2022

Published by: Comenius University in Bratislava, Faculty of Pharmacy

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

coronary heart disease,

Related subjects:

Pharmacy, other

© 2022 S. Kosirova, D. Rubintova, J. Lacka, J. Klimas, T. Foltanova, I. Tumova, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 69 (2022): Issue 1 (January 2022)Next article